Approval has been received for the change of market segment to the Standard Market; trading will occur on the Standard Market from 2026-11-02 onward. The plan to maintain listing standards for the Prime Market has been withdrawn.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"price_fetched_at":"","company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4574","jir_company_name":"Taiko Pharmaceutical Co.,Ltd.","jir_importance":"\u2605\u2605\u2605\u2606\u2606","jir_publication_date":"2026-10-26","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/10\/4574-20261026-01.pdf","jir_short_summary":"Approval has been received for the change of market segment to the Standard Market; trading will occur on the Standard Market from 2026-11-02 onward. The plan to maintain listing standards for the Prime Market has been withdrawn.","jir_summary":"### Formal Approval of Market Segment Change and Rationale\nTaiko Pharmaceutical Co.,Ltd. has received approval from the Tokyo Stock Exchange for a change of market segment to the Standard Market. The company explains that, from the perspective of long-term management strategy and maximizing shareholder value, the Standard Market is judged to be the market segment appropriate for its current business scale and growth stage. Consequently, efforts to comply with the Prime Market listing maintenance standards will not continue, and the plan has been withdrawn.\n\n### Future Schedule and Impact\nThe scheduled date for the market segment change is 2026-11-02, after which trading will take place on the Standard Market. No additional measures related to the transition to the Standard Market are specifically described, and the company will continue to aim to maintain and enhance shareholder value.","jir_financial_highlights":"Scheduled date of market segment change: 2026-11-02 (Change\/New)","jir_category":"","jir_hashtags":"#AvoidedShareBuybackInfo, #MarketSegmentChange","jir_key_figures":"Scheduled date of market segment change: 2026-11-02\nStart date of trading on the Standard Market after transition: Same day\nPlan to maintain listing standards for the Prime Market: Withdrawn","jir_meta_title":"Taiko Pharmaceutical Co.,Ltd. Approved to Move to the Standard Market; Plan Withdrawn\uff5c2026-11-02","jir_meta_description":"Taiko Pharmaceutical Co.,Ltd. has been approved to change its market segment to the Standard Market and has withdrawn its plan to maintain Prime Market listing standards. Key points on the transition date and future trading segment are summarized.","jir_og_title":"Taiko Pharmaceutical Co.,Ltd. Approved to Move to the Standard Market; Plan Withdrawn","jir_og_description":"Taiko Pharmaceutical Co.,Ltd. will move to the Standard Market and has withdrawn its plan to maintain Prime Market listing standards. Summary of the transition date and implications for investors.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":58317,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"disclosure_update","footnotes":""},"sector":[],"importance":[],"class_list":["post-134373","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n